Arca
Skip to content
Tools
Tools

Limb spasticity

Drug research and approvals for limb spasticity: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 45 studies of limb spasticity are recruiting on ClinicalTrials.gov, Health Canada has authorized 5 drug trials for it since 2013, and FDA has 2 approved and 0 open orphan designations naming it.

  • Recruiting worldwide: 45
  • Trials authorized in Canada: 5
  • FDA orphan approvals: 2
  • EU medicines: 0

Recruiting now

Newest posted first, of 45 recruiting on ClinicalTrials.gov ↗

Trials authorized in Canada

Newest first; search them all in Canada trials
Sep 2, 2021A multicentre, interventional, post-marketing, randomised, double-blind, crossover study to evaluate the clinical safety and efficacy of abobotulinumtoxina…Dysport therapeutic / BotoxIpsenClosed
Jul 9, 2014Long-term study of botox treatment in adult patients with upper limb spasticityBotox (onabotulinumtoxina)AbbViePending
May 23, 2014Propective, randomised, double-blind, placebo-controlled, parallel-group study of the efficacy and safety of nt 201 in the unilateral treatment of essential…Nt 201 (XEOMIN)Merz GroupOngoing
May 1, 2014Botox treatment in adult patients with upper limb spasticityBotoxAbbVieClosed
Dec 4, 2013Prospective, multicenter, randomized, double-blind, parallel-group, dose-response study of three doses xeomin (incobotulinumtoxin a, nt 201) for the treatment…NT201 [xeomin (incobotulinumtoxin a)]Merz GroupPending

FDA orphan designations

Approved first, then open designations, newest first
Jun 20, 2019BotoxBOTOX is indicated for the treatment of upper limb spasticity in pediatric patients 2 to 17 years of age.Allergan, Inc.Approved
Jul 29, 2016DysportTreatment of lower limb spasticity in pediatric patients 2 years of age and olderIpsen Biopharmaceuticals, Inc.Approved

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.